메뉴 건너뛰기




Volumn 76, Issue 3, 2012, Pages 457-464

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

(26)  Di Maio, Massimo a   Signoriello, Simona b   Morabito, Alessandro a   Rossi, Antonio c   Maione, Paolo c   Piantedosi, FrancoVito d   Bilancia, Domenico e   Cigolari, Silvio f   Barbera, Santi g   Gebbia, Vittorio h   Daniele, Bruno i   Robbiati, Sergio Federico j,o   Illiano, Alfonso d   Ceribelli, Anna k   Carrozza, Francesco l   Favaretto, Adolfo m   Piazza, Elena n   Piccirillo, Maria Carmela a   Daniele, Gennaro a   Giordano, Pasqualina a   more..


Author keywords

Advanced NSCLC; Education; Prognosis; Socioeconomic status

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL TRIAL; EDUCATION; FEMALE; GENDER; HUMAN; ITALY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL;

EID: 84860543344     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.01.002     Document Type: Article
Times cited : (15)

References (21)
  • 1
    • 15244361216 scopus 로고    scopus 로고
    • Social determinants of health inequalities
    • Marmot M. Social determinants of health inequalities. Lancet 2005, 365:1099-1104.
    • (2005) Lancet , vol.365 , pp. 1099-1104
    • Marmot, M.1
  • 5
    • 37849007302 scopus 로고    scopus 로고
    • Influence of education level on cancer survival in Sweden
    • Hussain S.K., Lenner P., Sundquist J., Hemminki K. Influence of education level on cancer survival in Sweden. Ann Oncol 2008, 19:156-162.
    • (2008) Ann Oncol , vol.19 , pp. 156-162
    • Hussain, S.K.1    Lenner, P.2    Sundquist, J.3    Hemminki, K.4
  • 6
    • 13444291449 scopus 로고    scopus 로고
    • Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations
    • Huisman M., Kunst A.E., Bopp M., Borgan J.K., Borrell C., Costa G., et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet 2005, 365:493-500.
    • (2005) Lancet , vol.365 , pp. 493-500
    • Huisman, M.1    Kunst, A.E.2    Bopp, M.3    Borgan, J.K.4    Borrell, C.5    Costa, G.6
  • 7
    • 77950914679 scopus 로고    scopus 로고
    • Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden
    • Berglund A., Holmberg L., Tishelman C., Wagenius G., Eaker S., Lambe M. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden. Thorax 2010, 65:327-333.
    • (2010) Thorax , vol.65 , pp. 327-333
    • Berglund, A.1    Holmberg, L.2    Tishelman, C.3    Wagenius, G.4    Eaker, S.5    Lambe, M.6
  • 8
    • 42449091057 scopus 로고    scopus 로고
    • Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status
    • Ou S.H., Zell J.A., Ziogas A., Anton-Culver H. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 2008, 112:2011-2020.
    • (2008) Cancer , vol.112 , pp. 2011-2020
    • Ou, S.H.1    Zell, J.A.2    Ziogas, A.3    Anton-Culver, H.4
  • 9
    • 0028843552 scopus 로고
    • Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group
    • Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995, 311:899-909.
    • (1995) BMJ , vol.311 , pp. 899-909
  • 10
    • 11144357752 scopus 로고    scopus 로고
    • Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
    • Gridelli C., Ardizzoni A., Le Chevalier T., Manegold C., Perrone F., Thatcher N., et al. Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol 2004, 15:419-426.
    • (2004) Ann Oncol , vol.15 , pp. 419-426
    • Gridelli, C.1    Ardizzoni, A.2    Le Chevalier, T.3    Manegold, C.4    Perrone, F.5    Thatcher, N.6
  • 11
    • 0006453669 scopus 로고    scopus 로고
    • Effects of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer
    • The Elderly Lung cancer Vinorelbine Italian Study group
    • The Elderly Lung cancer Vinorelbine Italian Study group Effects of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer. J Natl Cancer Inst 1999, 91:66-72.
    • (1999) J Natl Cancer Inst , vol.91 , pp. 66-72
  • 12
    • 0037420202 scopus 로고    scopus 로고
    • MILES Investigators Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung cancer in the Elderly Study (MILES) phase III randomized trial
    • Gridelli C., Perrone F., Gallo C., Cigolari S., Rossi A., Piantedosi F., et al. MILES Investigators Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003, 95:362-372.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 362-372
    • Gridelli, C.1    Perrone, F.2    Gallo, C.3    Cigolari, S.4    Rossi, A.5    Piantedosi, F.6
  • 13
    • 0041912766 scopus 로고    scopus 로고
    • Gemcitabine plus vinorelbine compared to cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer. A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada - Clinical Trials Group
    • Gridelli C., Gallo C., Shepherd F.A., Illiano A., Piantedosi F., Robbiati S.F., et al. Gemcitabine plus vinorelbine compared to cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer. A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada - Clinical Trials Group. J Clin Oncol 2003, 21:3025-3034.
    • (2003) J Clin Oncol , vol.21 , pp. 3025-3034
    • Gridelli, C.1    Gallo, C.2    Shepherd, F.A.3    Illiano, A.4    Piantedosi, F.5    Robbiati, S.F.6
  • 14
    • 34249320128 scopus 로고    scopus 로고
    • GECO investigators Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study
    • Gridelli C., Gallo C., Ceribelli A., Gebbia V., Gamucci T., Ciardiello F., et al. GECO investigators Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. Lancet Oncol 2007, 8:500-512.
    • (2007) Lancet Oncol , vol.8 , pp. 500-512
    • Gridelli, C.1    Gallo, C.2    Ceribelli, A.3    Gebbia, V.4    Gamucci, T.5    Ciardiello, F.6
  • 15
    • 33845382806 scopus 로고
    • Non parametric estimation from incomplete observation
    • Kaplan E.L., Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958, 53:457-481.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 16
    • 0013886333 scopus 로고
    • Evaluation of survival data and two new rank order statistics arising in its consideration
    • Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chem Rep 1966, 50:163-170.
    • (1966) Cancer Chem Rep , vol.50 , pp. 163-170
    • Mantel, N.1
  • 17
    • 0029851283 scopus 로고    scopus 로고
    • A note on quantifying follow-up in studies of failure time
    • Schemper M., Smith T.L. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996, 17:343-346.
    • (1996) Control Clin Trials , vol.17 , pp. 343-346
    • Schemper, M.1    Smith, T.L.2
  • 18
    • 0000336139 scopus 로고
    • Regression models and life tables
    • Cox D.R. Regression models and life tables. J Roy Stat Soc 1972, B34:187-220.
    • (1972) J Roy Stat Soc , vol.B34 , pp. 187-220
    • Cox, D.R.1
  • 19
    • 51649114276 scopus 로고    scopus 로고
    • Patient education level as a predictor of survival in lung cancer clinical trials
    • Herndon J.E., Kornblith A.B., Holland J.C., Paskett E.D. Patient education level as a predictor of survival in lung cancer clinical trials. J Clin Oncol 2008, 26:4116-4123.
    • (2008) J Clin Oncol , vol.26 , pp. 4116-4123
    • Herndon, J.E.1    Kornblith, A.B.2    Holland, J.C.3    Paskett, E.D.4
  • 20
    • 27244438585 scopus 로고    scopus 로고
    • Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study
    • Maione P., Perrone F., Gallo C., Manzione L., Piantedosi F., Barbera S., et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005, 23:6865-6872.
    • (2005) J Clin Oncol , vol.23 , pp. 6865-6872
    • Maione, P.1    Perrone, F.2    Gallo, C.3    Manzione, L.4    Piantedosi, F.5    Barbera, S.6
  • 21
    • 0029828975 scopus 로고    scopus 로고
    • Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences
    • Dale W., Vijayakumar S., Lawlor E.F., Merrell K. Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences. Prostate 1996, 29:271-281.
    • (1996) Prostate , vol.29 , pp. 271-281
    • Dale, W.1    Vijayakumar, S.2    Lawlor, E.F.3    Merrell, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.